1. Home
  2. IPA

IPA

ImmunoPrecise Antibodies Ltd.

Logo ImmunoPrecise Antibodies Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.

Founded: 1983 Country:
Canada
Canada
Employees: N/A City: N/A
Market Cap: 33.9M IPO Year: 2017
Target Price: $7.00 AVG Volume (30 days): 604.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.41 EPS Growth: N/A
52 Week Low/High: $0.94 - $4.22 Next Earning Date: 03-14-2024
Revenue: $17,671,642 Revenue Growth: 16.75%
Revenue Growth (this year): 20.18% Revenue Growth (next year): 21.26%

Share on Social Networks: